BioRestorative Therapies, Inc. (BRTX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

BioRestorative Therapies, Inc. (BRTX) closed at USD 1.50 on 2026-10-14, a change of -4.5 % over the past year, with a market capitalization of USD 2.02M.

BioRestorative Therapies, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

BioRestorative Therapies, Inc. key figures

Previous close

USD 1.50 (2026-10-14)

1-year change

-4.5 %

Market cap

USD 2.02M

Enterprise value

USD -1.7M

P/E ratio (trailing)

-0.07

P/E ratio (forward)

-0.14

EPS (trailing)

-21.49

EPS (forward)

-10.40

PEG ratio

n/a

Price to book

0.61

Revenue growth

-7.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.37

Employees

13

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for BioRestorative Therapies, Inc. and compare it with other stocks.